Carpenter, D. J., Fairchild, A., Adamson, J., Moravan, M. J. J., Fecci, P., Herndon, J., … Floyd, S. R. (2022). Outcomes in Intact and Resected Brain Metastasis Patients Treated with Five-Fraction Stereotactic Radiosurgery. In INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (Vol. 114, pp. E49–E50).

Carpenter, D. J., A. Fairchild, J. Adamson, MJ Jr Moravan, P. Fecci, J. Herndon, T. C. Mullikin, et al. “Outcomes in Intact and Resected Brain Metastasis Patients Treated with Five-Fraction Stereotactic Radiosurgery.” In INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 114:E49–50, 2022.

Carpenter DJ, Fairchild A, Adamson J, Moravan MJJ, Fecci P, Herndon J, et al. Outcomes in Intact and Resected Brain Metastasis Patients Treated with Five-Fraction Stereotactic Radiosurgery. In: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2022. p. E49–50.

Carpenter, D. J., et al. “Outcomes in Intact and Resected Brain Metastasis Patients Treated with Five-Fraction Stereotactic Radiosurgery.” INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, vol. 114, no. 3, 2022, pp. E49–50.

Carpenter DJ, Fairchild A, Adamson J, Moravan MJJ, Fecci P, Herndon J, Mullikin TC, Reitman Z, Kirkpatrick JP, Torok JAJ, Floyd SR. Outcomes in Intact and Resected Brain Metastasis Patients Treated with Five-Fraction Stereotactic Radiosurgery. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2022. p. E49–E50.